Genetics of Chronic Kidney Disease in Low-Resource Settings.

[1]  A. Köttgen,et al.  Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. , 2022, Kidney international.

[2]  Alicia R. Martin,et al.  Diversity in Genomic Studies: A Roadmap to Address the Imbalance , 2022, Nature Medicine.

[3]  P. Tan,et al.  Multicenter study on the genetics of glomerular diseases among southeast and south Asians: Deciphering Diversities ‐ Renal Asian Genetics Network (DRAGoN) , 2022, Clinical genetics.

[4]  M. Woodward,et al.  Prevalence of chronic kidney disease in Asia: a systematic review and analysis , 2022, BMJ Global Health.

[5]  Max W. Y. Lam,et al.  Improving Polygenic Prediction in Ancestrally Diverse Populations , 2021, Nature Genetics.

[6]  P. Yenchitsomanus,et al.  Association between intelectin-1 variation and human kidney stone disease in northeastern Thai population , 2021, Urolithiasis.

[7]  A. Sinha,et al.  Next-Generation Sequencing for Congenital Nephrotic Syndrome: A Multi-Center Cross-Sectional Study from India , 2021, Indian Pediatrics.

[8]  L. Onuchic,et al.  APOL1 in an ethnically diverse pediatric population with nephrotic syndrome: implications in focal segmental glomerulosclerosis and other diagnoses , 2021, Pediatric Nephrology.

[9]  N. Powe,et al.  Race and Genetic Ancestry in Medicine - A Time for Reckoning with Racism. , 2021, The New England journal of medicine.

[10]  D. Adu,et al.  Overview of The Human Heredity and Health in Africa Kidney Disease Research Network (H3A-KDRN). , 2020, Kidney360.

[11]  C. Khor,et al.  Genome-Wide Meta-Analysis Identifies Three Novel Susceptibility Loci and Reveals Ethnic Heterogeneity of Genetic Susceptibility for IgA Nephropathy. , 2020, Journal of the American Society of Nephrology : JASN.

[12]  S. Sengupta,et al.  Frequency spectrum of rare and clinically relevant markers in multiethnic Indian populations (ClinIndb): A resource for genomic medicine in India , 2020, Human mutation.

[13]  D. Goldstein,et al.  Rare genetic causes of complex kidney and urological diseases , 2020, Nature Reviews Nephrology.

[14]  Deepa Bhat,et al.  Comprehensive Rare Disease Care model for screening and diagnosis of rare genetic diseases - an experience of private medical college and hospital, South India. , 2020, Intractable & rare diseases research.

[15]  A. Morris,et al.  Discovery and fine-mapping of kidney function loci in first genome-wide association study in Africans , 2020, bioRxiv.

[16]  L. A. Teixeira,et al.  New problems of a new health system: the creation of a national public policy of rare diseases care in Brazil (1990s-2010s). , 2020, Salud colectiva.

[17]  L. G. Vu,et al.  Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The Lancet.

[18]  S. Marie,et al.  Brazilian Network of Pediatric Nephrotic Syndrome (REBRASNI) , 2019, Kidney international reports.

[19]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[20]  Markus S. Schröder,et al.  The GenomeAsia 100K Project enables genetic discoveries across Asia , 2019, Nature.

[21]  C. Langefeld,et al.  Effect of a Single Apolipoprotein L1 Gene Nephropathy Variant on the Risk of Advanced Lupus Nephritis in Brazilians , 2019, The Journal of Rheumatology.

[22]  Max W. Y. Lam,et al.  Genome-wide Association Studies in Ancestrally Diverse Populations: Opportunities, Methods, Pitfalls, and Recommendations , 2019, Cell.

[23]  V. R. Rajendran,et al.  Genomics of rare genetic diseases—experiences from India , 2019, Human Genomics.

[24]  Karsten B. Sieber,et al.  A catalog of genetic loci associated with kidney function from analyses of a million individuals , 2019, Nature Genetics.

[25]  C. Jayasumana.  Chronic Interstitial Nephritis in Agricultural Communities (CINAC) in Sri Lanka. , 2019, Seminars in nephrology.

[26]  Alicia R. Martin,et al.  Clinical use of current polygenic risk scores may exacerbate health disparities , 2019, Nature Genetics.

[27]  Cristian Riella,et al.  APOL1-Associated Kidney Disease in Brazil , 2019, Kidney international reports.

[28]  Jitender Saini,et al.  INDEX-db: The Indian Exome Reference Database (Phase I) , 2019, J. Comput. Biol..

[29]  L. Hindorff,et al.  Defining and Achieving Health Equity in Genomic Medicine. , 2019, Ethnicity & disease.

[30]  M. Mills,et al.  A scientometric review of genome-wide association studies , 2019, Communications Biology.

[31]  James M. Eales,et al.  Trans-ethnic kidney function association study reveals putative causal genes and effects on kidney-specific disease aetiologies , 2019, Nature Communications.

[32]  A. Kengne,et al.  An African perspective on the genetic risk of chronic kidney disease: a systematic review , 2018, BMC Medical Genetics.

[33]  Ankit Verma,et al.  SAGE: a comprehensive resource of genetic variants integrating South Asian whole genomes and exomes , 2018, Database J. Biol. Databases Curation.

[34]  A. Mokdad,et al.  Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. , 2018, Kidney international.

[35]  F. Schaefer,et al.  Exploring the Clinical and Genetic Spectrum of Steroid Resistant Nephrotic Syndrome: The PodoNet Registry , 2018, Front. Pediatr..

[36]  B. Jaar,et al.  Burden of chronic kidney disease on the African continent: a systematic review and meta-analysis , 2018, BMC Nephrology.

[37]  S. Mane,et al.  Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[38]  J. Pesquero,et al.  Targeted Next-Generation Sequencing in Brazilian Children With Nephrotic Syndrome Submitted to Renal Transplant , 2017, Transplantation.

[39]  K. Girisha,et al.  India Allele Finder: a web-based annotation tool for identifying common alleles in next-generation sequencing data of Indian origin , 2017, BMC Research Notes.

[40]  Christopher R. Gignoux,et al.  Human demographic history impacts genetic risk prediction across diverse populations , 2016, bioRxiv.

[41]  Kathleen F. Kerr,et al.  African Ancestry-Specific Alleles and Kidney Disease Risk in Hispanics/Latinos. , 2017, Journal of the American Society of Nephrology : JASN.

[42]  P. Kimmel,et al.  Genomic approaches to the burden of kidney disease in Sub-Saharan Africa: the Human Heredity and Health in Africa (H3Africa) Kidney Disease Research Network. , 2016, Kidney international.

[43]  D. Friedman,et al.  Apolipoprotein L1 and Kidney Disease in African Americans , 2016, Trends in Endocrinology & Metabolism.

[44]  P. Kimmel,et al.  Human Heredity and Health (H3) in Africa Kidney Disease Research Network: A Focus on Methods in Sub-Saharan Africa. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[45]  A. Adeyemo,et al.  HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome. , 2015, Journal of the American Society of Nephrology : JASN.

[46]  S. Chew,et al.  Identification of new susceptibility loci for IgA nephropathy in Han Chinese , 2015, Nature Communications.

[47]  Andrew D. Moran.  South Asia. , 2021, Global heart.

[48]  Tesfaye B Mersha,et al.  Self-reported race/ethnicity in the age of genomic research: its potential impact on understanding health disparities , 2015, Human Genomics.

[49]  Murim Choi,et al.  Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens , 2014, Nature Genetics.

[50]  M. McCarthy,et al.  Research Capacity: Enabling African Scientists to Engage Fully in the Genomic Revolution , 2014 .

[51]  C. Rotimi,et al.  Evolution of the primate trypanolytic factor APOL1 , 2014, Proceedings of the National Academy of Sciences.

[52]  S. Naicker,et al.  The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. , 2014, The Lancet. Global health.

[53]  R. Yamada,et al.  An Integrative Study of the Genetic, Social and Environmental Determinants of Chronic Kidney Disease Characterized by Tubulointerstitial Damages in the North Central Region of Sri Lanka , 2014, Journal of occupational health.

[54]  F. Salzano,et al.  Interethnic admixture and the evolution of Latin American populations , 2013, Genetics and molecular biology.

[55]  D. Friedman,et al.  Genetics of kidney failure and the evolving story of APOL1. , 2011, The Journal of clinical investigation.

[56]  Francisco M. De La Vega,et al.  Genomics for the world , 2011, Nature.

[57]  M. Hutz,et al.  The Genomic Ancestry of Individuals from Different Geographical Regions of Brazil Is More Uniform Than Expected , 2011, PloS one.

[58]  Anirban Dutta,et al.  Indian genetic disease database , 2010, Nucleic Acids Res..

[59]  Debasis Dash,et al.  IGVBrowser–a genomic variation resource from diverse Indian populations , 2010, Database J. Biol. Databases Curation.

[60]  C. Winkler,et al.  The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. , 2010, Journal of the American Society of Nephrology : JASN.

[61]  C. Winkler,et al.  Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans , 2010, Science.

[62]  F. Hildebrandt.  Genetic kidney diseases , 2010, The Lancet.

[63]  P. Majumder.  The Human Genetic History of South Asia , 2010, Current Biology.

[64]  Jin Ok Yang,et al.  Mapping Human Genetic Diversity in Asia , 2009, Science.

[65]  Eduardo Barrientos,et al.  Analysis of genomic diversity in Mexican Mestizo populations to develop genomic medicine in Mexico , 2009, Proceedings of the National Academy of Sciences.

[66]  C. Chan,et al.  Parallel genotyping of 10,204 single nucleotide polymorphisms to screen for susceptible genes for IgA nephropathy. , 2000, Annals of the Academy of Medicine, Singapore.

[67]  D. Vlahov,et al.  MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis , 2008, Nature Genetics.

[68]  D. Reich,et al.  MYH9 is associated with nondiabetic end-stage renal disease in African Americans , 2008, Nature Genetics.

[69]  R. Brasseur,et al.  Apolipoprotein L-I is the trypanosome lytic factor of human serum , 2003, Nature.

[70]  M. Tanner,et al.  Band 3 mutations, distal renal tubular acidosis, and Southeast Asian ovalocytosis. , 2002, Kidney international.

[71]  B. Kiberd,et al.  Cumulative risk for developing end-stage renal disease in the US population. , 2002, Journal of the American Society of Nephrology : JASN.

[72]  International Human Genome Sequencing Consortium.  Initial sequencing and analysis of the human genome , 2001, Nature.

[73]  L. Vanhamme,et al.  A VSG Expression Site–Associated Gene Confers Resistance to Human Serum in Trypanosoma rhodesiense , 1998, Cell.

[74]  P. Jarolim,et al.  Deletion in erythrocyte band 3 gene in malaria-resistant Southeast Asian ovalocytosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.